Hønnås Arne, Reimers Arne, Spigset Olav
Avdeling for klinisk farmakologi, St. Olavs hospital, 7006 Trondheim, Norway.
Tidsskr Nor Laegeforen. 2010 Jul 1;130(13):1334-6. doi: 10.4045/tidsskr.09.1163.
In 2007, new Norwegian guidelines suggested that serum concentrations of digitoxin should be in the interval 8 - 15 nmol/l, which is about 50 % lower than previous recommendations.
We studied trends in dosing and serum concentrations of digitoxin in the period 2000 - 08, based on 13 054 serum samples sent to our laboratory for analysis in that period.
The median serum concentration of digitoxin was stable until the end of 2006 (at about 25 nmol/l); then it gradually decreased from 2007 until the end of 2008 (to 19 nmol/l). The mean daily dose decreased from 66 microg to 56 microg in the study period. At a given dose, patients above 85 years of age had serum concentrations that were almost twice as high as those for patients younger than 55 years. This age effect was particularly pronounced from 65 years.
Serum concentrations of digitoxin have gradually decreased after 2007, but are often higher than the new reference range. To obtain serum concentrations within the new reference interval, doses at least as low as those currently recommended should be used, particularly in the oldest patients.
2007年,挪威新指南建议洋地黄毒苷的血清浓度应在8 - 15纳摩尔/升之间,这比之前的建议值低约50%。
我们基于2000年至2008年期间送至我们实验室进行分析的13054份血清样本,研究了该时间段内洋地黄毒苷的给药趋势和血清浓度。
洋地黄毒苷的血清浓度中位数在2006年底前保持稳定(约为25纳摩尔/升);随后从2007年至2008年底逐渐下降(降至19纳摩尔/升)。研究期间平均每日剂量从66微克降至56微克。在给定剂量下,85岁以上患者的血清浓度几乎是55岁以下患者的两倍。这种年龄效应从65岁起尤为明显。
2007年后洋地黄毒苷的血清浓度逐渐下降,但仍常高于新的参考范围。为使血清浓度处于新的参考区间内,应使用至少与当前推荐剂量一样低的剂量,尤其是在老年患者中。